The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in Brain
Abstract
Chronic treatment of rats with the neuroleptic drugs haloperidol, fluphenazine, and reserpine elicits a 20 to 25 percent increase in striatal dopamine receptor binding assayed with [ 3 H]haloperidol. This increase in receptor sites may account for behavioral supersensitivity to dopamine receptor stimulants in such animals and for tardive dyskinesia in patients treated with these drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Self-citationAntipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
PRE AND POSTSYNAPTIC RECEPTORS
Rees, D. (1976) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.39.10.1035 · Cited by 775
Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
Seeman, P., Chau-Wong, M., Tedesco, J., & Wong, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4376 · Cited by 701
The Pharmacology of Tardive Dyskinesias
KLAWANS, H. L. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.1.82 · Cited by 511
Membrane Receptors and Hormone Action
Cuatrecasas, P., & Hollenberg, M. D. (1976) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60481-7 · Cited by 478
BURT, D. R., CREESE, I., & SNYDER, S. H. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10800-6 · Cited by 475
Self-citationTarsy, D., & Baldessarini, R. J. (1974) · Neuropharmacology · doi:10.1016/0028-3908(74)90084-7 · Cited by 446
Creese, I., Burt, D. R., & Snyder, S. H. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90454-3 · Cited by 390
Self-citationAn experimental model of tardive dyskinesia
Klawans, H. L., & Rubovits, R. (1972) · Journal of Neural Transmission · doi:10.1007/bf01245320 · Cited by 275
Cited by
ROBINSON, T., & BECKER, J. (1986) · Brain Research · doi:10.1016/s0006-8993(86)80193-7 · Cited by 2,106
Robinson, T. E., & Becker, J. B. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90002-0 · Cited by 1,796
Trajectories of brain development: point of vulnerability or window of opportunity?
Andersen, S. L. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00005-8 · Cited by 1,503
“Again, these developmental findings are completely opposite to the well-known effects of these agents during adulthood, and receptor antagonism leads to receptor upregulation or supersensitivity [44].”
BackgroundFarde, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070032005 · Cited by 1,419
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988
Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive Schizophrenics
Wong, D. F., Wagner, H. N., Tune, L. E., Dannals, R. F., Pearlson, G. D., Links, J. M., Tamminga, C. A., Broussolle, E. P., Ravert, H. T., Wilson, A. A., et al. (1986) · Science · doi:10.1126/science.2878495 · Cited by 932
Self-citationLong-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding
Peroutka, S. J., & Snyder, S. H. (1980) · Science · doi:10.1126/science.6251550 · Cited by 832
Self-citationImaging Dopamine Receptors in the Human Brain by Positron Tomography
Wagner, H. N., Burns, H. D., Dannals, R. F., Wong, D. F., Langstrom, B., Duelfer, T., Frost, J. J., Ravert, H. T., Links, J. M., Rosenbloom, S. B., et al. (1983) · Science · doi:10.1126/science.6604315 · Cited by 741
GABAergic modulation of benzodiazepine binding site sensitivity
TALLMAN, J. F., THOMAS, J. W., & GALLAGER, D. W. (1978) · Nature · doi:10.1038/274383a0 · Cited by 722
Increased dopamine transmission in schizophrenia: relationship to illness phases
Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 715
Dopamine Receptor Binding Enhancement Accompanies Lesion-Induced Behavioral Supersensitivity
Creese, I., Burt, D. R., & Snyder, S. H. (1977) · Science · doi:10.1126/science.877576 · Cited by 712
Self-citationKapur, S., Zipursky, R. B., & Remington, G. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.286 · Cited by 712
Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs
Farde, L. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250087012 · Cited by 692
Buchsbaum, M. S. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290030001001 · Cited by 535
Farde, L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150013003 · Cited by 530
INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA
Owen, F., Crow, T. J., Poulter, M., Cross, A. J., Longden, A., & Riley, G. J. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91740-3 · Cited by 518
Skirboll, L. R., Grace, A. A., & Bunney, B. S. (1979) · Science · doi:10.1126/science.482929 · Cited by 501
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
Laruelle, M., & Abi-Dargham, A. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300405 · Cited by 461
The pathophysiology of extrapyramidal side-effects of neuroleptic drugs
Marsden, C. D., & Jenner, P. (1980) · Psychological Medicine · doi:10.1017/s003329170003960x · Cited by 449
Receptor basis for dopaminergic supersensitivity in Parkinson's disease
LEE, T., SEEMAN, P., RAJPUT, A., FARLEY, I. J., & HORNYKIEWICZ, O. (1978) · Nature · doi:10.1038/273059a0 · Cited by 446
Monnet, F. P., Mahé, V, Robel, P., & Baulieu, E. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3774 · Cited by 429
Increased Brain Dopamine and Dopamine Receptors in Schizophrenia
Mackay, A. V. P. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090001001 · Cited by 397
Post, R. M. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90085-5 · Cited by 384
Kaar, S. J., Natesan, S., McCutcheon, R., & Howes, O. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107704 · Cited by 383
Identification of PSD-95 as a Regulator of Dopamine-Mediated Synaptic and Behavioral Plasticity
Yao, W.-D., Gainetdinov, R. R., Arbuckle, M. I., Sotnikova, T. D., Cyr, M., Beaulieu, J.-M., Torres, G. E., Grant, S. G. N., & Caron, M. G. (2004) · Neuron · doi:10.1016/s0896-6273(04)00048-0 · Cited by 380
Neurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365
Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains
LEE, T., SEEMAN, P., TOURTELLOTTE, W. W., FARLEY, I. J., & HORNYKEIWICZ, O. (1978) · Nature · doi:10.1038/274897a0 · Cited by 351
What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?
Correll, C. U., Rubio, J. M., & Kane, J. M. (2018) · World Psychiatry · doi:10.1002/wps.20516 · Cited by 324
Yokoi, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00304-4 · Cited by 313
Silvestri, S., Seeman, M. V., Negrete, J.-C., Houle, S., Shammi, C. M., Remington, G. J., Kapur, S., Zipursky, R. B., Wilson, A. A., Christensen, B. K., et al. (2000) · Psychopharmacology · doi:10.1007/s002130000532 · Cited by 311
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.1.16 · Cited by 301
Muller, P., & Seeman, P. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90155-2 · Cited by 300
The physiology and pharmacology of mammalian basal ganglia
Dray, A. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90017-9 · Cited by 293
Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor Supersensitivity
Pert, A., Rosenblatt, J. E., Sivit, C., Pert, C. B., & Bunney, W. E. (1978) · Science · doi:10.1126/science.566468 · Cited by 285
Crossman, A. R. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90322-8 · Cited by 282
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477313 · Cited by 270
Dopaminergic Mechanisms in Idiopathic and Drug-induced Psychoses
Lieberman, J. A., Kinon, B. J., & Loebel, A. D. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.1.97 · Cited by 274
Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome
Singer, H. S., Hahn, I., & Moran, T. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300408 · Cited by 273
Drug and Neurotransmitter Receptors in the Brain
Snyder, S. H. (1984) · Science · doi:10.1126/science.6322304 · Cited by 273
Self-citationDopaminergic supersensitivity after neuroleptics: time-course and specificity
Muller, P., & Seeman, P. (1978) · Psychopharmacology · doi:10.1007/bf00429171 · Cited by 271
Samaha, A.-N., Seeman, P., Stewart, J., Rajabi, H., & Kapur, S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5416-06.2007 · Cited by 262
Clonidine Ameliorates Gilles de la Tourette Syndrome
Cohen, D. J. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780250036004 · Cited by 263
Buspirone: review of its pharmacology and current perspectives on its mechanism of action
Eison, A. S., & Temple, D. L. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90325-6 · Cited by 258
Chapter 10 Functional roles of dopamine in the vertebrate retina
Witkovsky, P., & Dearry, A. (1991) · Progress in Retinal Research · doi:10.1016/0278-4327(91)90031-v · Cited by 252
The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics
O’Donnell, K. C., & Gould, T. D. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.002 · Cited by 137
Waltz, J. A., Frank, M. J., Wiecki, T. V., & Gold, J. M. (2011) · Neuropsychology · doi:10.1037/a0020882 · Cited by 132
Xu, H. (2010) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2010.00008 · Cited by 108
Dilsaver, S. C., & Greden, J. F. (1984) · Brain Research Reviews · doi:10.1016/0165-0173(84)90028-6 · Cited by 73
Emsley, R., Asmal, L., Rubio, J. M., Correll, C. U., & Kane, J. M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.025 · Cited by 41
Metadata
- Authors
- Burt, D. R., Creese, I., & Snyder, S. H.
- Venue
- Science
- Published
- 1977-04-15
- Volume
- 196
- Issue
- 4287
- Pages
- 326-328
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1975216040
- Cited by
- 1,024
- References
- 22
- FWCI
- 21.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.